Applies to: Device manufacturers marketing in the United States
What Is QMSR and Why It Matters?
The Quality Management System Regulation (QMSR) is the FDA's mandatory framework governing how medical device manufacturers design, produce, package, label, store, and service their devices. Effective February 2, 2026, the QMSR replaced the previous Quality System Regulation (QSR) and incorporated by reference ISO 13485:2016, aligning FDA's requirements with the internationally recognized standard for medical device quality management systems. Any manufacturer engaged in the production of finished devices intended for the U.S. market is required to establish and maintain a quality management system that complies with the QMSR. Non-compliance renders a device adulterated under the Federal Food, Drug, and Cosmetic Act and exposes manufacturers to FDA enforcement actions, including warning letters, import alerts, and product seizure.
How Can We Help?
At Certilance, we help medical device manufacturers build, implement, and maintain a quality management system that fully complies with the QMSR and its incorporated ISO 13485:2016 requirements. Whether you are establishing a QMS for the first time, transitioning from the previous QSR framework, or preparing for an FDA inspection, our consultants guide you through every element of the regulation with a structured and practical approach. We assess your current quality system, identify gaps, and work alongside your team to implement the processes, procedures, and documentation needed to meet FDA expectations and keep your operations inspection-ready.
FAQ
QMSR — frequently asked questions
Yes. Medical devices must obtain FDA clearance or approval before being marketed in the United States. The pathway depends on device classification, intended use, and risk profile.
The U.S. Food and Drug Administration (FDA) regulates devices through:
- 510(k) premarket notification
- De Novo classification
- Premarket Approval (PMA)
Each pathway has different evidence, testing, and review requirements.
No. CE marking and FDA approval are completely separate regulatory systems. Compliance with one does not grant access to the other market.
FDA does not formally certify ISO standards. However, an ISO 13485-aligned quality system strongly supports FDA Quality System Regulation (QSR) compliance and significantly reduces inspection findings.
Certilance helps manufacturers prepare documentation, quality systems, and regulatory evidence aligned with FDA expectations, ensuring submissions and inspections proceed efficiently.
FDA timelines vary by pathway (510(k), De Novo, or PMA) and submission quality. While FDA review periods are defined, real-world timelines are often extended due to deficiency letters, additional data requests, or design control gaps.
Early regulatory alignment significantly reduces delays.
FDA-related costs depend on:
- Regulatory pathway
- Testing and validation requirements
- Submission complexity
- FDA user fees (where applicable)
Well-structured submissions reduce review cycles and overall cost exposure.
FDA Compliance
Related services
QMSR
Ready to start your QMSR project?
Book a free consultation and we will map the gaps, the timeline and the cost before any work begins.